U-Blot® Research Grade DonanemabCat. No. WA2692$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade DonanemabCat. No. WA2692
U-Blot® Research Grade DomvanalimabCat. No. WA2691
U-Blot® Research Grade DomagrozumabCat. No. WA2690
U-Blot® Research Grade DocaravimabCat. No. WA2689
U-Blot® Research Grade DivozilimabCat. No. WA2688
U-Blot® Research Grade DisitamabCat. No. WA2687
U-Blot® Research Grade DiridavumabCat. No. WA2686
U-Blot® Research Grade DinutuximabCat. No. WA2685
U-Blot® Research Grade DilpacimabCat. No. WA2684
U-Blot® Research Grade DibotatugCat. No. WA2683
U-Blot® Research Grade DezamizumabCat. No. WA2682
U-Blot® Research Grade DevextinetugCat. No. WA2681